Microbial Methanol Pathway for Reducing Equivalents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing commercial quantities of 3-hydroxyisobutyrate and methacrylic acid face limitations due to insufficient reducing equivalents, which hinder maximum product yields from carbohydrate feedstocks.
Innovation Solution
Engineering non-naturally occurring microbial organisms with methanol metabolic pathways that enhance reducing equivalents availability, combined with 3-hydroxyisobutyrate or methacrylic acid pathways, using enzymes such as methanol methyltransferase and succinyl-CoA transferase, to increase yields of these organic compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional carbohydrate feedstock is used for producing 3-hydroxyisobutyrate and methacrylic acid, then the production process is simple, but the product yield is limited due to insufficient reducing equivalents
Solution Approach 1:
The patent combines methanol metabolism pathways with 3-hydroxyisobutyrate and methacrylic acid production pathways in a single microbial organism. The methanol metabolic pathway generates reducing equivalents (NADH, NADPH) that are directly utilized by the product synthesis pathways, merging two functional systems to resolve the reducing equivalent deficiency while maintaining integrated metabolic flow.
Solution Approach 2:
Methanol serves as an intermediary substrate that is metabolized to generate reducing equivalents, which then act as mediators to enable enhanced product synthesis. The methanol pathway includes intermediate compounds (formaldehyde, formate) that are processed through enzymatic steps to produce the necessary reducing power without directly incorporating methanol carbon into the final product.
2Productivity
If methanol metabolic pathway is introduced to enhance reducing equivalents availability, then product yield increases, but the organism requires additional exogenous nucleic acids and enzymes
Solution Approach 1:
The methanol metabolic pathway is segmented into discrete enzymatic steps, each catalyzed by a specific enzyme encoded by separate exogenous nucleic acid sequences. This segmentation allows for modular introduction of pathway components (e.g., formaldehyde dehydrogenase, formate dehydrogenase) that can be independently optimized and regulated, managing genetic complexity through structured modularity.
Solution Approach 2:
The patent alters key metabolic parameters by introducing exogenous enzymes with optimized catalytic properties. The expressed enzymes exhibit enhanced specific activities and substrate affinities compared to endogenous counterparts, changing kinetic parameters (Km, Vmax) to favor increased reducing equivalent production while maintaining pathway flux control.
3Quantity of substance
If methanol is used as a substrate to generate reducing equivalents, then the availability of reducing equivalents increases, but the metabolic pathway requires multiple enzymatic steps
Solution Approach 1:
The methanol metabolic pathway performs preliminary oxidation of methanol to formaldehyde and formate before the carbon enters the central metabolism. This preliminary action generates reducing equivalents in advance, preparing the cellular redox state for enhanced product synthesis without requiring complex regulatory mechanisms during the main production phase.
Solution Approach 2:
The methanol metabolic pathway operates continuously to supply reducing equivalents, with enzymatic steps proceeding in an unbroken sequence from methanol oxidation through formaldehyde and formate metabolism. This continuous action ensures steady-state availability of NADH and NADPH, maintaining constant driving force for product synthesis without intermittent bottlenecks.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach significantly enhances the production of 3-hydroxyisobutyrate and methacrylic acid by utilizing methanol to generate reducing equivalents, thereby maximizing product yields from glucose under both aerobic and anaerobic conditions.
Implementation Method 1
methanol metabolic pathway that can enhance the availability of reducing equivalents in the presence of methanol
Implementation Method 2
The E. coli strain of the present invention comprises an exogenous nucleic acid encoding a formaldehyde dehydrogenase and an exogenous nucleic acid encoding a formate dehydrogenase
Data Source
AI summary
Provided herein is a non-naturally occurring microbial organism having a methanol metabolic pathway that can enhance the availability of reducing equivalents in the presence of methanol. Such reducing equivalents can be used to increase the product yield of organic compounds produced by the microbial organism, such as 3-hydroxyisobutyrate or MAA. Also provided herein are methods for using such an organism to produce 3-hydroxyisobutyrate or MAA.